Related Experiment Videos
Rapid Resolution of Psoriasis Following Low-Dose Interleukin-2 Monotherapy: A Case Report
Doudou Ma1,2, Zhanguo Li1
1Department of Rheumatology and Immunology, Peking University People's Hospital, Beijing, People's Republic of China.
Biologics : Targets & Therapy
|May 27, 2026
Summary
Low-dose interleukin-2 (IL-2) monotherapy offers a promising new treatment for psoriasis. A patient refractory to topical treatments experienced significant improvement and remained lesion-free after 80 days of IL-2 therapy.
Area of Science:
- Immunology
- Dermatology
- Pharmacology
Background:
- Psoriasis is a chronic, immune-mediated inflammatory skin condition.
- Current therapies have limitations, with some patients experiencing inadequate response or adverse effects.
- Refractory psoriasis poses a significant clinical challenge.
Related Concept Videos
01:24T Cell Types and Functions
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...